非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版)

被引:140
作者
Chinese Society of Endocrinology
Chinese Medical Association
机构
[1] 中华医学会内分泌学分会
关键词
非酒精性脂肪性肝病; 代谢综合征X; 诊断; 治疗学; 共识;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
100201 [内科学];
摘要
<正>非酒精性脂肪性肝病(NAFLD)是指除外过量饮酒和其他明确的损肝因素所致的肝细胞内脂肪沉积,包括从单纯的肝脂肪变性(NAFL)到非酒精性脂肪性肝炎(NASH),以致一部分最终发展为肝硬化,甚至演变为肝细胞癌(HCC)。目前,NAFLD全球及亚洲人群患病率约为25%[1-2]。我国NAFLD患病率也不容乐观,因检测方法不同,中国成人NAFLD患病率
引用
收藏
页码:2103 / 2108
页数:6
相关论文
共 36 条
[1]
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.[J].Alessandro Mantovani;Gianluigi Zaza;Christopher D. Byrne;Amedeo Lonardo;Giacomo Zoppini;Enzo Bonora;Giovanni Targher.Metabolism.2018,
[2]
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases [J].
Adams, Leon A. ;
Anstee, Quentin M. ;
Tilg, Herbert ;
Targher, Giovanni .
GUT, 2017, 66 (06) :1138-1153
[3]
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].
Armstrong, Matthew James ;
Gaunt, Piers ;
Aithal, Guruprasad P. ;
Barton, Darren ;
Hull, Diana ;
Parker, Richard ;
Hazlehurst, Jonathan M. ;
Guo, Kathy ;
Abouda, George ;
Aldersley, Mark A. ;
Stocken, Deborah ;
Gough, Stephen C. ;
Tomlinson, Jeremy W. ;
Brown, Rachel M. ;
Huebscher, Stefan G. ;
Newsome, Philip N. .
LANCET, 2016, 387 (10019) :679-690
[4]
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].
Ballestri, Stefano ;
Zona, Stefano ;
Targher, Giovanni ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Nascimbeni, Fabio ;
Roverato, Alberto ;
Guaraldi, Giovanni ;
Lonardo, Amedeo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944
[5]
I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders [J].
Xia, M. -F. ;
Ling, Y. ;
Bian, H. ;
Lin, H. -D. ;
Yan, H. -M. ;
Chang, X. -X. ;
Li, X. -M. ;
Ma, H. ;
Wang, D. ;
Zhang, L. -S. ;
Wang, S. -S. ;
Wu, B. -J. ;
He, W. -Y. ;
Zhao, N. -Q. ;
Gao, X. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (05) :631-642
[6]
Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study [J].
Koehler, Edith M. ;
Plompen, Elisabeth P. C. ;
Schouten, Jeoffrey N. L. ;
Hansen, Bettina E. ;
Murad, Sarwa Darwish ;
Taimr, Pavel ;
Leebeek, Frank W. G. ;
Hofman, Albert ;
Stricker, Bruno H. ;
Castera, Laurent ;
Janssen, Harry L. A. .
HEPATOLOGY, 2016, 63 (01) :138-147
[7]
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial [J].
Neuschwander-Tetri, Brent A. ;
Loomba, Rohit ;
Sanyal, Arun J. ;
Lavine, Joel E. ;
Van Natta, Mark L. ;
Abdelmalek, Manal F. ;
Chalasani, Naga ;
Dasarathy, Srinivasan ;
Diehl, Anna Mae ;
Hameed, Bilal ;
Kowdley, Kris V. ;
McCullough, Arthur ;
Terrault, Norah ;
Clark, Jeanne M. ;
Tonascia, James ;
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Doo, Edward .
LANCET, 2015, 385 (9972) :956-965
[8]
Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study [J].
Lin, Huandong ;
Li, Qian ;
Liu, Xiaojing ;
Ma, Hui ;
Xia, Mingfeng ;
Wang, Dan ;
Li, Xiaoming ;
Wu, Jiong ;
Zhao, Naiqing ;
Pan, Baishen ;
Gao, Xin .
PLOS ONE, 2015, 10 (10)
[9]
The Global Burden of Liver Disease: The Major Impact of China [J].
Wang, Fu-Sheng ;
Fan, Jian-Gao ;
Zhang, Zheng ;
Gao, Bin ;
Wang, Hong-Yang .
HEPATOLOGY, 2014, 60 (06) :2099-2108
[10]
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease [J].
Kozlitina, Julia ;
Smagris, Eriks ;
Stender, Stefan ;
Nordestgaard, Borge G. ;
Zhou, Heather H. ;
Tybjaerg-Hansen, Anne ;
Vogt, Thomas F. ;
Hobbs, Helen H. ;
Cohen, Jonathan C. .
NATURE GENETICS, 2014, 46 (04) :352-+